Search results
15 results found
Review of genomic technologies for NHS ScotlandCase studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland
Personalised medicine and the UK insurance sectorCase studyAs part of the partnership between the University of Cambridge and Aviva, we were asked to produce a report examining the changing obligations on the UK insurance sector as personalised medicine becomes available.
Innovative ‘omics technologies for personalised medicineCase studyThe AHSN Network commissioned PHG Foundation to undertake an evidence review of genomics and genomic technologies likely to impact the delivery of personalised medicine in the NHS in the next two to three years.
Born healthy: tackling the burden of birth defectsCase studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland
Brokering the conversationCase studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland
Can genomics help tackle the obesity epidemic?Case studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland
The challenges of data sharingCase studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland
Delivering safer antenatal testingCase studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland
Embedding genomics in the UK health systemCase studyThe 2020 Clinical genome analysis evidence review from PHG Foundation fed directly into strategic planning for the design and provision of clinical genetic services in Scotland